Literature DB >> 24836423

The susceptibility of Trypanosoma congolense and Trypanosoma brucei to isometamidium chloride and its synthetic impurities.

Annelise Sahin1, Corinne Asencio1, Julien Izotte1, Davita Pillay1, Virginie Coustou1, Hamadi Karembe2, Théo Baltz3.   

Abstract

Since the 1950s, the chemotherapy of animal African trypanosomosis in cattle has essentially relied on only two compounds: isometamidium chloride (ISM), a phenanthridine, and diminazene aceturate, an aromatic diamidine. The commercial formulations of ISM, including Veridium(®) and Samorin(®), are a mixture of different compounds: ISM is the major component, mixed with the red isomer, blue isomer and disubstituted compound. To investigate the pharmacological effects of these individual compounds ISM, the blue and red isomers and the disubstituted compound were synthesised and purified by HPLC. The activity of each compound was analysed both in vitro, and in mice in vivo. For the in vitro analysis, a drug sensitivity assay was developed in 96-well tissue culture plates to determine the effective concentration which killed 50% of trypanosome population within 48 h of drug exposure (IC50). All compounds tested in vitro possessed trypanocidal activity, and purified ISM was the most active. Veridium(®) and Samorin(®) had similar IC50 values to purified ISM for both Trypanosoma congolense and Trypanosoma brucei brucei. The disubstituted compound had the highest IC50 values whereas intermediate IC50 values were obtained for the blue and red isomers. In vivo, single-dose tests were used to evaluate the trypanocidal and prophylactic activity against T. congolense. Interestingly, the prophylactic effect two months post treatment was as efficient with ISM, Veridium(®), Samorin(®) and the disubstituted compound at the highest dose of 1mg/kg whereas the red and blue isomers both showed much lower prophylactic activity. This study on T. congolense implies that it is necessary to limit the quantity of the blue and red isomers in the commercial mixture. Finally, the in vitro sensitivity assay may be useful for screening new trypanocides but also for the testing and detection of resistant trypanosome isolates.
Copyright © 2014 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Drug sensitivity; Isomers; Isometamidium; Trypanosoma

Mesh:

Substances:

Year:  2014        PMID: 24836423     DOI: 10.1016/j.vetpar.2014.04.002

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  6 in total

1.  Comparative Sensitivity and Specificity of the 7SL sRNA Diagnostic Test for Animal Trypanosomiasis.

Authors:  Maria Contreras Garcia; Emily Walshe; Pieter C Steketee; Edith Paxton; Javier Lopez-Vidal; Michael C Pearce; Keith R Matthews; Fatima Ezzahra-Akki; Alec Evans; Karen Fairlie-Clark; Jacqueline B Matthews; Finn Grey; Liam J Morrison
Journal:  Front Vet Sci       Date:  2022-04-05

Review 2.  The animal trypanosomiases and their chemotherapy: a review.

Authors:  Federica Giordani; Liam J Morrison; Tim G Rowan; Harry P DE Koning; Michael P Barrett
Journal:  Parasitology       Date:  2016-10-10       Impact factor: 3.234

3.  Genomic analysis of Isometamidium Chloride resistance in Trypanosoma congolense.

Authors:  Eliane Tihon; Hideo Imamura; Frederik Van den Broeck; Lieve Vermeiren; Jean-Claude Dujardin; Jan Van Den Abbeele
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-10-06       Impact factor: 4.077

Review 4.  An Update on African Trypanocide Pharmaceutics and Resistance.

Authors:  Keneth Iceland Kasozi; Ewan Thomas MacLeod; Ibrahim Ntulume; Susan Christina Welburn
Journal:  Front Vet Sci       Date:  2022-03-07

5.  New Trypanosoma evansi Type B Isolates from Ethiopian Dromedary Camels.

Authors:  Hadush Birhanu; Tadesse Gebrehiwot; Bruno Maria Goddeeris; Philippe Büscher; Nick Van Reet
Journal:  PLoS Negl Trop Dis       Date:  2016-04-01

6.  The individual components of commercial isometamidium do not possess stronger trypanocidal activity than the mixture, nor bypass isometamidium resistance.

Authors:  Anthonius A Eze; John Igoli; Alexander I Gray; Graham G Skellern; Harry P De Koning
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-01-21       Impact factor: 4.077

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.